Literature DB >> 20712467

Palliative treatment of malignant ascites #177.

Karen LeBlanc1, Robert M Arnold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20712467     DOI： 10.1089/jpm.2010.9799

Source DB:  PubMed          Journal:  J Palliat Med        ISSN： 1557-7740            Impact factor:   2.947


× No keyword cloud information.
  3 in total

1.  A survey of treatment approaches of malignant ascites in Germany and Austria.

Authors:  C F Jehn; S Küpferling; G Oskay-Özcelik; D Lüftner
Journal:  Support Care Cancer       Date:  2014-12-21       Impact factor: 3.603

Review 2.  Catumaxomab: in malignant ascites.

Authors:  James E Frampton
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

3.  A pilot study of long-acting octreotide for symptomatic malignant ascites.

Authors:  Aminah Jatoi; Jorge J Nieva; Rui Qin; Charles L Loprinzi; Edward J Wos; Paul J Novotny; Dennis F Moore; Rex B Mowat; Naftali Bechar; Eduardo R Pajon; Lynn C Hartmann
Journal:  Oncology       Date:  2012-05-10       Impact factor: 2.935
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.